The Latest Analyst Ratings For Edwards Lifesciences
The Latest Analyst Ratings For Edwards Lifesciences
爱德华兹生命科学的最新分析师评级
Ratings for Edwards Lifesciences (NYSE:EW) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有9位分析师提供了爱德华兹生命科学（纽约证券交易所代码：EW）的评级，显示了看涨和看跌的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $91.56, a high estimate of $103.00, and a low estimate of $77.00. Observing a 10.15% increase, the current average has risen from the previous average price target of $83.12.
分析师12个月目标股价的见解已经公布，平均目标股价为91.56美元，最高估计为103.00美元，低估值为77.00美元。目前的平均价格上涨了10.15％，已从之前的平均目标价83.12美元上涨。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The standing of Edwards Lifesciences among...
通过对分析师...
登录免费看全文
登录/注册